Related Experiment Video
Updated: Mar 20, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Digital health for the End TB Strategy: developing priority products and making them work
Dennis Falzon1, Hazim Timimi2, Pascal Kurosinski3
1Global TB Programme, World Health Organization, Geneva, Switzerland falzond@who.int.
Novel digital health solutions are crucial for achieving the World Health Organization's End Tuberculosis (TB) Strategy by 2035. Engaging diverse stakeholders is key to developing and implementing these innovations for better TB care and prevention.
Area of Science:
- Public Health
- Health Informatics
- Global Health
Background:
- The World Health Organization (WHO) launched the End Tuberculosis (TB) Strategy in 2014, aiming to eradicate the global TB epidemic by 2035.
- Significant advancements are required to overcome challenges in TB care, affecting healthcare professionals, patients, and communities.
- Information and communication technology (ICT) offers promising avenues for innovative TB interventions.
Purpose of the Study:
- To outline the approach of the WHO Global Task Force on Digital Health for TB in advancing digital health innovations.
- To align digital health strategies with the three pillars of the End TB Strategy.
- To identify priority digital health concepts and products for enhancing national TB programs.
Main Methods:
- The WHO Global Task Force on Digital Health for TB was established in April 2015.
- The task force's approach focuses on stewarding the development of digital health innovations.
- Target product profiles were developed to define priority digital health concepts and products.
Main Results:
- Nine priority digital health concepts and products were identified by early 2016.
- These innovations are strategically positioned to improve TB action at the country level.
- Successful large-scale implementation necessitates engagement from patients, caregivers, innovators, policymakers, and communities.
Conclusions:
- Digital health holds significant potential to support TB patient care, surveillance, program management, and e-learning.
- Collaborative efforts among diverse stakeholders are essential for the effective development and deployment of digital health solutions.
- The identified digital health innovations are critical for achieving the global End TB Strategy goals.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Affecting Factors
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:

